No Data
Analysts Are Bullish on Top Healthcare Stocks: Sarepta Therapeutics (SRPT), Schrodinger (SDGR)
BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $28
Schrödinger, Inc.'s (NASDAQ:SDGR) Intrinsic Value Is Potentially 44% Above Its Share Price
Schrödinger, Inc. (NASDAQ:SDGR) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Express News | Schrodinger Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results
Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating, Announces Target Price $30
Buy n Die Together❤ :
73610841 : Adrian Nathaniel carter, I can’t tag him and we’re Facebook friends, does anyone know why?
Seth Beaty : Though you know if you bet against Cathie Wood, you’ll probably make money.
Rob banks : is there an ETF for this ai medical sector?
Chak : is it goid time yo
get into TEM ?
View more comments...